Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$1.35M-$1.35Mderivedno prior Q4 2018 on file EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$1,353,500—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,142,918— Free Cash Flowderived-$1,082,318— ended Sep 30, 2019 · filed Dec 20, 2019 · 81 d after period end